Category Archives: Neuroscience

Cape Fear Valley to build center to train doctors. Here’s what that means for Cumberland County. – The Fayetteville Observer

Steve DeVane|The Fayetteville Observer

Cape Fear Valley Health is building a $30 million facility for its growing medical residency program.

The 120,000-square-feet Center for Medical Education and Research at theMelrose Road and Owen Drive also will be home of the health systems Neuroscience Institute.

The health system held a groundbreaking ceremony for the center last month. Officials say the state-of-the-art facility is expected to attract residents, physicians and specialists to the area.

The residency program is a partnership between the health system and the Jerry M. Wallace School of Osteopathic Medicine at Campbell University.

More:Cape Fear Valley increases pay in effort to attract nurses

Dr. Donald Maharty, Cape Fear Valleys vice president for medical education, said the residency program has 133 residents, which is near its capacity. The new center will allow the program to expand to 300 residents and help train about 100 medical students from Campbell.

Maharty said expanding the residency program will help deal with a shortage of doctors in North Carolina. About half of the 25 residents who have graduated or are about to graduate have indicated that they plan to stay in the Cumberland County area, he said.

Ultimately, improving access and quality of healthcare is our main focus, he said.

The estimated economic impact of the residency program over 10 years is $580 million, Maharty said.

The programs impact is similar to a company bringing more than 900 jobs to the area, according to hospital officials.

Maharty said the new center will include 5,000 square feet of simulation labs. The facility will include a fully simulated operating room and labor and delivery room. Doctors also will get training that simulates what they face in emergency rooms and intensive care units.

All of this adds to enhanced training and patient safety, he said.

Dr. Charles Haworth, physician leader at Cape Fear Valley Neurosurgery, said the Neuroscience Institute in the center will allow the hospital to integrate services in a central location. For example, computer-generated 3-D models of a patients brain or spine can help surgeons decide how best to approach each situation.

In general, youre trying to do something as minimally invasive as possible ... and youre trying to solve the problem, he said.

The center also will provide a modern facility for the institute, Haworth said.

I think we need a top-notch building to house our people so we can attract other top-notch physicians, he said.

Dr. Melissa Stamates, a physician with Cape Fear Valley Neurosurgery, said the center will lead to a higher quality of care. The facility will let the doctors communicate with patients over a secure email program.

Patients will get more information about their brains and spines, she said.

More: COVID-19 cases in Cumberland County follow downward trend

Cape Fear Valley Health Foundation, the philanthropic arm of the hospital, is raising $6 million toward the cost of the center, according to Jaime Powell, the foundations gifts officer. She said about 80% of that has been raised, including gifts from The Duke Endowment, the Thomas R. and Elizabeth E. McLean Foundation, the Cape Fear Valley Health Volunteer Auxiliary, the Golden LEAF Foundation, and the Cape Fear Valley Health Foundation.

Powell said the groundbreaking kicked off the public phase of the fundraising campaign, which hopes to raise $1.3 million. That effort is led by the foundations volunteer Caring for the Future Committee, which is co-chaired by Virginia Thompson Oliver and Tony Cimaglia.

Other funding for the center was provided by Campbell University and the state.

Sabrina Brooks, the foundations administrative director, said members of the community are stepping up to help pay for the center.

This is one of the most transformational projects that Cape Fear Valley has taken on, she said.

Support local journalism with a subscription to The Fayetteville Observer. Click the "subscribe'' link at the top of this article.

Staff writer Steve DeVane can be reached at sdevane@fayobserver.com or 910-486-3572.

See the rest here:
Cape Fear Valley to build center to train doctors. Here's what that means for Cumberland County. - The Fayetteville Observer

Dean Burnett on the neuroscience of mental illness – BBC Focus Magazine

Sara Rigby: Hello and welcome to the Science Focus Podcast. Im Sara Rigby, online assistant at BBC Science Focus magazine. In the UK, one in four people experience a mental health problem each year. The reality of living with common problems like depression and anxiety is increasingly well known. But how much do you actually know about whats going on in your brain when your mental health suffers? Neuroscientist Dean Bennett, author of the new book Psycho-logical, is here to tell us all about it.

So can you first please just tell us what your book is about?

Dean Burnett: Its Psycho-logical. Two words, very clever. Its basically a book about mental health, but not Unlike most mental health books you find in the market, all of which I find, its not a sort of slur against anyone else, but its a book about mental health as a process, as a scientific phenomenon, which we, sort of, we have a recognition of, an understanding of whats going on internally when our mental health declines or suffers or is compromised in some way. Because theres a big push now, has been for many years, for mental health awareness, to raise awareness of it and to increase understanding. But personally, Ive always felt that as good as that is and as noble and as useful there is, awareness is only part of the battle. I think you need to have an understanding of whats going wrong before you can really have any sort of genuine appreciation for the matters. Because if Im being very pessimistic, I would say the majority of mental health awareness campaigns, you can boil the message down to something like: depression is real, pass it on. Which is fine. Its a very valid thing to say. But its also like, well, thats not really the most persuasive argument. So I thought, well, given I spent 20 years dabbling Dabbling? Im not a dabbler. Im a neuroscientist. Ive got a PhD and everything. SA bit of that imposter syndrome phenomenon. But, um, yeah. So I know Ive been working on neuroscience for well over 20 years now and from undergraduate level and I spent like seven years as a psychiatry lecturer for a masters course. So my knowledge and experience is very much a wide range in terms of the underlying science rather than the actual everyday experience. So I thought, well, maybe theres room for that side of things to say, like, well, yes, we all know most people agree that mental health problems are genuinely real things and they affect us all in many different ways. And if they dont affect us directly, society itself is affected by them. But why? Why does this happened, whats going on in our heads when mental health declines, what we know about it and what can be done about it and why does it keep happening? Thats the sort of questions I wanted to tackle in this book, particularly. So its focused on mental health, but the actual the science of it insofar as we know. So thats what I that was my attempt to do. And some people might read it and think I failed. But that was the that was the intention.

SR: So generally speaking, what is it in our brains that can go so wrong and cause mental health problems?

DB: Well, thats a hole with no bottom, isnt it?

Theres a lot happening in that brain, which in any one part of which can be compromised in some way, which can suffer for it. Pure quirks of biology to the external experiences to unrecognised issues of development. There are so many different factors which feed into it. And like a mental health problem manifest in so many both varied and intangible ways.

I mean, you cant Thats one of the big problems I address early on in that theres a lot of comparisons made lately with between mental and physical health problems. And I think my my argument would be that there are times when that is a very valid thing to do, that is suitable and helpful approach. When youre dealing with someone who doesnt recognise mental health problems or doesnt agree that they are a thing, it is almost inevitable that you will contextualise them in the form of something they will recognise. Or even if someone says depression is not real, theres no such thing as mental health problems. You very rarely find a single person who would say the same thing about physical ailments because everyones had something at some point. I mean, the human body is not a perfectly flawless machine. You dont go through life never having even as much as a stubbed toe or a cold or a headache or a broken bone or an injury of some sort. So these are, you know, people recognise these. And if they dont have themselves, they can see other people have around them. And you can see them. You can see like, well, what we know how the human body is meant to look. So if its growing extra lumps and its turned green, thats wrong. Theres something really, really going awry there. But you cant really do that with mental health problems because the manifestation of them in the real physical world is other peoples behaviour, which is always changing, always in flux, because we are complex creatures. But even having said all that, I thought, well, it would be good to maybe try and impose some tangible aspect to it by looking at the brain, since thats where all our thoughts and behaviours and emotions and moods arise from. So theres plenty go on. The brain can go physically awry or physically wrong. And we can look at that and say, well, thats whats causing this mental health problem to recognise it.

So in terms of the underlying biology, theres a lot of things going on, but a lot of it seems to come down to were talking about the more common mental health ailments, were talking anxiety and depression and things related to those come down to, sort of, it seems to be an end result of stress in some form. And stress, its a common term now, sorry to say, in almost an offhand manner. So work stress or the stress of everyday life, but its due to genuine physiological process in that its the precursor to the fight or flight response, like your body getting warmed up to deal with dangers and threats. And the way I describe it is if the fight or flight response is like the big bad boss in the computer game, stress is the hordes of minions they send at you that you have to wade to to get to that point. And theyre not as potent and powerful as the big boss.

But they can do a lot of damage. Theres more of them than they wear you down eventually. And one thing, as impressive and brilliant as the human brain is, and all its evolved to do, one thing and seemingly hasnt evolved to do it so far as its evolved to do anything. Evolution doesnt have an endpoint. It just keeps happening. But long term chronic stress isnt something the brain has a good ability to deal with because it to happen in the wild, things that stress you out would be immediate dangers and threats or things like that. Even if its like low food supply, when you find something, the stress goes away. But because we have these big, powerful brains, we can envisage scenarios which will negatively impact us without physically hurting.

Its like losing a job or a relationship going sour or people get stressed out by the idea of the economy going downhill and their savings not having as much value. These are things which do not have any direct physical impact on you and you have no control over. But you can worry about them and they might never happen. People can get really stressed out about things which havent happened and may never happen. And sometimes we get stressed about things which definitely did not happen and now cannot happen. Weve probably all done it. Like you think, you cross the road and a car speeds past. Oh, a second earlier, if I crossed earlier that could have hit me, Id be killed. And that stresses out that didnt happen.

We know that. But it cannot physically happen, we cant go back in time.

But we get stressed anyway. So and the constant low level of stress chemicals impacts on our brain and body in various different ways. And it can lower the immune system, can exhaust neurones. Thats one of the leading theories of how depression works. Now, its not about chemical imbalances as kind of an old school theory. No, its not that the chemicals arent gone different how they should be. But that seems to be more of a symptom, not a cause, in that neurones become exhausted by the constant stress chemicals. So they were shut down. Theyre going to stand by like they just do the bare minimum what they can. And some of those are parts of the brain which control mood and how we change mood and shift and respond well to things. So that feeds in quite nicely a lot of the typical symptoms of depression, the inability to change from a low mood, inability to feel anything in response to something positive or the complete lack of motivation. It makes sense to think big chunks of my neural networks, which allows behaviour thats currently suppressed, have just been spent by the stress response. And similarly, in different parts of the brain, the stress chemicals are like the threat recognition, recognition stimulate those parts of the brain, which keep us on edge and look for dangers. And if those parts are overworked, maybe theyll become like a muscle. They get more powerful and stronger. They tip the balance and therefore you get anxiety when people are constantly worried about things, which may not be there. There is a low level state of panic because the part of your brain which respond to threats and dangers are now being overworked and they get overstimulated and sort of beefed up. And that is a very simplistic way of looking at it in that its obviously a lot more complex than that. But if you look in these terms, you can understand all that. It makes perfect sense that would happen because the modern world is so generous with things, the stresses out and the human brain can find them even randomly. And therefore, you get all these abundant cases of anxiety and depression and things like that because the world is seemingly set up and the brain works to the way that these things are pretty much inevitable.

SR: Right. So lets talk more specifically about depression. And if, as you say, the the world is generally quite, quite stressful, surely were all exposed to that. So what what is it that triggers depression in particular people and not in everybody?

DB: Yeah, thats a very valid point. Were all kind of expose to that. To me, I think its sort of misleading to think there will be one root cause of depression or any mental health problem. Its always going to be a combination of factors like the heritability factors when it comes to depression, people of certain types from certain families. They have a higher risk of depression, so like if your parents or one of your parents had depression, like the odds of you having depression increased because you dont have the right genetic factors which lead to it, or lead to a vulnerability to it. But that doesnt mean that if you have this gene, you will have depression. If you dont, you wont. Its just no, its a balance of risks. And that if the average person is five per cent chance of having depression, then someone with this gene that will have 10 per cent chance, both unlikely, but one is twice as unlikely as the other and so on. So there will be genetic factors which link in things like certain gene which doesnt, which is so slightly distorted or just different to the point where it doesnt produce enough growth hormone, which means part your brain wont be as resilient or well-connected as others, and therefore depression can occur because it doesnt lead to the stress and so on and so on. So little things like that and childhood experiences, if you were growing up in a sort of more traumatic environment or just a less stable, more chaotic, more confusing, more stressful one, then your brain will develop in certain ways which perhaps will be wary of stress or seek it out even more, because youve grown up thinking, well, I should be, my childhood experiences say that the world is a dangerous place, so I will be constantly wary of dangerous things.

And therefore you look out, then you become more stressed that way, or even just like nutrition. You dont build up the physical resilience in terms of how the brain works to fend off things. I mean, the brain, theres so much redundancy and its so much failsafe and so much extra processing which can take over, its all flexible that in people with brain injury can make good recoveries, especially the young, because the brain is still developing and well find workarounds. But these abilities are finite. And some people, if youve been dealing with stress a long time or if youre already sort of running in a bit of a loss is a way of saying it. But if youre already dealing with a predisposition to stress or low mood, your brains constantly working harder to fix that, to do that, to deal with the consequences of that so that when something else happens, like a particularly strong life stress, like the stress scale, like the maximum thing that can happen is the death of a partner, the death of a spouse. And it goes down from there like things like like retirement can be very stressful if you plan to do it, because its a massive change your life. Divorce and things like that. These are all big triggers of stress. And if you already have a lot of stress to deal with, then that can be enough to push you over the edge and to right now, now your brains suddenly gone I genuinely cannot handle this anymore and therefore just dont spirals from there. Like, I cant handle this, Im going to shut down for a bit. And then you have your depression, you have your anxious episodes, you have you quote unquote, nervous breakdowns as people tend to refer to them. It will push you over the limit in the brain from can cope to cant cope. Where that line resides is going to differ for many different people. And someone predisposition. Some will have a lot of cognitive reserve and that can be a big deal. As lot of studies have shown that how adept and healthy, how much resource your brain has, can be a massive protective factor to stave off things like dementia. And if you have the underlying pathology people who have lived healthy lives and constantly kept learning things and stay active and use their brain, they tend to show very little symptom or sign of dementia, even if their brain has If you took a sample of their brain, surely this persons got terrible dementia, but they dont. And because the brains are alert and active and capable but for many people in the modern world doesnt allow them to build up this reserve, it takes and takes rather than allows them to give and give. And some people will end up with depression as a result of that. So, yeah, theres loads of factors, but its not, I think, important point that no ones a failure. If youve got depression, thats I think its the capacity to lead that sort of thinking. But its its going to happen in the way the world works. And its just its often the case of someone whos got depression or had depression, they had a lot more to deal with than most people.

SR: You mentioned earlier that bereavement was one of the most stressful events that the brain could deal with. So in in grief, people tend to feel a lot of the same sort of things as youd expect to be symptoms of depression. So, the low mood for a long period of time, things like that. So what exactly is the difference between grief and depression?

DB: Yeah, so obviously this is a very big issue at the moment because we live in the middle of a pandemic. And as I find myself, like I lost my father very early on the pandemic and it was very unexpected, he had no prior health problems. He wasnt even 60 yet and it came out of nowhere. And I had to deal with that all by myself. So I do delve into that, obviously, the book and stuff. And it was extremely traumatic, extremely debilitating and a very hard time. So I can speak from experience in this regard. And it was less than a year ago, I wouldnt say Im over it, but Im functioning and it can still be rough. Me being a neuroscientist who deals with mental health. Was that helpful for dealing with your own grief and stuff? I think it was in hindsight to me at the time, it didnt feel like it was helping, but I never got to the point where I couldnt function. So maybe there was a protective factor in knowing how this works, whats going on in my head when this is going on. But on the other hand, its also the analogy I use. Its like being a trained mechanic trapped in a car with no brakes on the motorway. You know, I know what the problem is. I cant do anything about it right now. Im just going to wait until this is over and hopefully Ill survive the whole thing. So, yeah. So it can be a helpful thing. So this is why I always try and educate people or say the more you know about whats going on, the more resilient you can be, because this is not scary or uncertain. Youve got a handle on whats happening. But back to question. Yeah. So how are you diagnose grief and depression is a it is a tricky one. It is actually.

Its an ongoing debate and it can be a source of controversy like the DSM, which is the the American Psychiatric Association, their go-to manual for what counts as a mental health problem or doesnt, a diagnosis or not. And the fifth edition was revised a few years back and people were quite alarmed by how many things now count as a psychiatric diagnosis that before youd think they were just general human behaviour, like people say tantrums, having tantrums is now recognised as a psychiatric problem. I think with kids just have a tantrum. That is another case of over medicalising, trying to sort of find problems. The pharmaceutical companies can charge the medicines and make a lot of money off. And thats definitely a problem which does have to be or should be addressed and paid more attention to. But the other side of the coin is the you know, the people would argue that before now, kids who had chronic tantrums to the point where they couldnt control the behaviour and their parents can do anything about it, which is clearly causing disruption, they would be diagnosed as having bipolar problems and would end up on far more severe medication, like far more powerful stuff, which you would rather not do for a small child. So if its a tantrum as a separate diagnosis, all you can do is that maybe you can give them a much milder intervention or some sort of therapy rather than powerful medications.

So theres two sides to every argument. The grief thing is a tricky one in that, like you say, when you lose someone close to you, its the most traumatic, harrowing experience possible. And you will show behaviour and think in an emotional and mood symptoms which are very similar to that depression. The general approach Id like to make out is that its a question of how long it lasts because people in grief will be laid low for weeks, months at a time, depends on the nature of how it happened. But if its like after six months, nine months, they still show no signs of any change in their behaviour and thinking, then thats where a chronic grief reaction comes in like this. OK, so now we can probably have some of the intervention here because they clearly arent moving on. They arent processing this. Its a serious emotional change with a huge emotional impact on them, and these things take time to work through, but they do eventually happen and the brain is adept at doing that, that we are very emotional creatures, but we also have a lot of processes in place in our brains to work through these things. And if youre not showing any sign of that, thats thats when you can sort of say, OK, this seems like its a problem rather than just the normal process. So it more comes down to how much change there is. I mean, thats how depression is sort of diagnosed anyway, not over a period of months, but weeks. And people have low moods all the time. You know, its very common to be sad about things, especially now were in the middle of a pandemic. You know, lots of things are going wrong and theres lots of things to be unhappy about in the wider world. So people being in a low mood state, being unhappy, being sad, being just like I cant be bothered, I cant do this anymore, is common. But the difference between that and depression is, A, severity. People with depression tend to be very, very low mood rather than just a brief melancholy. But perhaps even more indicative is how long this lasts because a mood doesnt normally last two weeks. Your mood can change a couple of days or you have ups and downs from the mood is unchanged or stays the same for two weeks or the best part thereof. Thats when you think, OK, this doesnt seem right because the brain doesnt do its the same constantly, the mood and emotion and thinking. So, yeah, it comes a lot of it comes down to just the duration of the symptoms rather than what the symptoms actually are themselves. Thats like a big, interesting aspect which people seem to not really recognise and that, yes, we have we all have these different emotions and all of these bad and good experiences. But how long they last can be the deciding factor between general brain behaviour and mental health problem.

SR: So, as you say, there will be a lot of people at the minute going to bereavements, not knowing what you know. Now, what advice would you give to them to, I suppose, experience grief in a in a healthy way?

DB: Yeah, its a little tricky in that obviously everyones going to be different. From each their own. People are going to have different experiences of what theyre going through, how it happens, how it manifests, who they have with them, what the situation is. Because like I would say, it was particularly hard for me when it happened because it was a middle of the earliest lockdown where we were cut off from family. I dont live down the road from my family. Im like 30 miles away from my closest relatives. So I had no one I could really depend on. Normally when this all happens, you lose someone very close to you, people rally around, they gather around. They do things for you, like they take care of the kids, the house, the cooking and stuff, and they just pop in to see if youre OK. Its a very human compulsion and a good one, a very healthy one. But we couldnt do that. On top of that, I live with my wife, my two small children. There were three. So it was lockdown. They were scared, out of school. They just lost their grandfather. They didnt know what was happening. So I couldnt really afford to indulge my grief in terms of just sitting around doing nothing, which is what I wanted to do. I had to still be strong and provide reassurance for them. So its really hard to do that. I did it and, you know, it did cost me, but I did it. And I was lucky enough to have the resources to do that. Ive lived a relatively charmed existence the past few years in terms of nothing particularly bad happening. You know, Ive no particular concerns and stuff. So its. Yeah. So like I was in the position where I could do that. I thought I was hit with a particularly hard version of it, but also had the resources to throw at it. Mentally, cognitively, and not everyone will have that. And I think its important to recognise that theres no particular path through grief which you have to take or you should be following. I mean, its a very common cultural reference. The whole five stages of grief, denial, anger, bargaining, acceptance or some variation of of that. I mean, it pops up in sitcoms all the time in films. And when you experience grief, you go through these five stages and thats how it works. But thats not really how it works at all in that I mean, the human brain is never that predictable, not reliable in any case, especially when it comes something which is a really profound emotional experience. Thats where it gets its most chaotic, most unpredictable. But even the psychiatrist who came up with these group stages, she never said originally that everyone will go through these stages of grief at all times and in this order, the more like a recognition of the path of grief which can occur more sort of common flustering things, and of this person grieving and they seem to be experiencing denial or this person seems very angry and thats fine. But it doesnt mean that thats before fear, thats after the denial. So theres no logic to that. So even if youre grieving and you find yourself confused by your emotions, your experiences, your reactions, then thats fine, theres no sort of template for this that you have to be following and I think its really important to keep that in mind. Everyones grief is going to be their own. Theyre going to know. I mean, I got very angry a lot for no reason. People messaged me with very positive things, expressing sorrow on my behalf and saying they wish they could help and stuff that was clearly well meant. Clearly a friendly gesture, clearly heartfelt, comes from a place of love. But I kept getting really angry at that at first and that you wish you could help. But, you know, you cant. Its a lockdown. My father died. Theres nothing you can do. This is making yourself feel better. How dare you? And I didnt say that to anyone, but it went through my head a lot and at the time it felt wrong. In hindsight, I realise now that thats OK. As long as I wasnt hurting anyone, I would express my feelings that way. Then so be it. Thats what Ill do. So yeah, I think its important to recognise, especially now when we sort of cut off from so much and we have so few options for. And mental stress or, you know, because I feel better, all your pastimes of leisure pursuits, it all cut off for the time being. So when you mention grief, you would be doing it in your own way. And thats important to recognise that your grief is your own. And if its going this way for you, then thats how it is. You know, if its going another way, thats fine. If you stay stuck in one place for too long, then, yeah, then you can sort of start being concerned. But if you work through it how you need to work through it then nobody can tell you that this is wrong, you should be doing this. Thats when it could be made worse, I think.

SR: So if someone is suffering from depression and they decide to go get help for it, they might get they might get prescribed some antidepressants. What do antidepressants actually do in the brain?

DB: Thats kind of an interesting one. I mean, I think to me its been a good sign that the mental health awareness campaigns are working in recent years because I started writing about stuff like this over at least 10, 15 years ago. Between that, not all the time, we still see a lot of arguments online Obviously online arguments, where else do arguments happen? We know that. But its people dismissing depression as a thing. Saying no, no such thing as depression. Its people attention-seeking, drama queens. Just snap out of it and all that sort of stuff. And you still get that occasionally from the more extreme controversial pundits. But more often than not, now depression is accepted as a real thing. Now its all go-to argument is that antidepressants arent a thing. Its a just a scam. Theyre just some big pharmaceutical companies push on us to make money, or like, you hear so many people encountering someone, and theyre like personal trainers, the first thing we do is get you off those pills and then its judgement and sort of stereotyping and pill shaming of people on antidepressants. So theres a lot of work to be done there. But, yes, its its a controversial area, I suppose, and written books about it and how you shouldnt take any depressants, which is wrong and bad in so many ways. And so what they do is If we turn to the class of antidepressants youve got in that There are lots of different variations available at the moment, like the mainstream ones which have been validated and sent through trials and just readily available and, you know, tricyclic amines, youve got monoamine oxidase inhibitors, youve got your SSRIs, your SNRIs and so on. But what they all do is some variation on increasing the levels of certain neurotransmitters in the brain, which I believe is where this whole chemical imbalance argument or belief comes from in that youve got your regular brain, youve got some levels of certain chemicals, namely neurotransmitters, which the brain needs to do everything it does. A set of neurones communicate with each other and in people with depression, in this case, some of those chemical levels are reduced for reasons unknown, and that causes depression. So if you can take an antidepressant, it puts those levels back up and that cures depression. That seems to be the assumption or the view of it by a lot of people. This chemical imbalance claim is quite widespread. But I mean, its logical to make that conclusion because its like antidepressants were discovered essentially by accident in the 50s when they were looking for different things to take on to deal with surgical shock and they found peoples mood sort of been elevated. And it took them long enough to know something was up here. And they found that there are anti-depressants and thats what they do, like they stop the removal of neurotransmitters after theyve been used. They stay around longer, so brings the levels back up and so on and so on. But the main thing is like the neurotransmitter antidepressants work on the chemical level right away. You take on your new levels are increased like minutes later. But most of the widely available antidepressants now, they take between two and three weeks to kick in, which is a long time. And its weird, because if they work straight away chemically, why do they take so long that any actual relief of the symptoms of depression. And this reveals that its not just on the chemical levels, its something more profound than that. Its been more deep and complex. And to go into like the neuroplasticity thing from earlier, its now sort of believed by many that what antidepressants do is they sort of slowly but surely build up the activity in these suppressed neurones by causing more activity to act on them, by boosting transmitter levels. So, sort of like blowing on the spark of a campfire, just like coaxing it back to life. And one of the things of that is that pretty much all modern antidepressants, not all, but all the main ones, they work on monoamine neurotransmitters, which are all the various neurotransmitters, you know, adrenaline, your dopamine, your oxytocin. These are all monoamine class. It just means like theres an amine molecule attached to the general thing, which are very important neurotransmitters in the brain. But they take up a relatively small percentage of the brain, sort of like in terms of how the brain mass is layered or how it works. The monoamine systems are like sort of the veins that run through marble. Kind of everywhere, but a small part of it. And so if you boost activity in the monoamine system, which all antidepressants do at the moment, pretty much all of them, they will have sort of a more slow and gradual effect because theyre not really affecting that many neurones in the brain. But the activities are spread out slowly, like fertilising a plant. You sort of just put it in there and it slowly seeps out. And but theres been sort of a lot of developments recently into more potent antidepressants. In 2019, in the States, the first ketamine antidepressant was released for use in early trials and stuff.

And its a nasal spray, not even a pill, and it seems to work the next day or maybe even a few hours, because ketamine, for all its faults, is a very potent chemical. It works on the glutamate system, which makes about 80 per cent of brain activity. So its rather than sort of blowing gently on a campfire, its sort of like cranking up the flame thrower and just firing at it. Just like, take this. Ahh!

And its like the brain just kicked up into, like several gears, like woah, hello!

SR: Sorry, Id just like to pause there for a second. So were not actually recommending that people go and take ketamine.

DB: Oh yeah, I was gonna get to that, yeah. So, so does that. And the same thing with hallucinogenics, like magic mushrooms and things of the chemical derived from those. They stimulate so much of the brain that its believed they can sort of get those sluggish neurones back to a regular activity a lot faster. But obviously the downside of that is you stimulate all the brain in one go with one chemical, youre stimulating all the brain in one go. The brain does a lot of things. That can be seriously dangerous if not done right and not done with extreme expert interventions and refinement. So I guess this is not a recommendation. Dont go find it and take it, because that will, well, if you do that, maybe depression will be the last your problems. Its going to cause a lot more problems than not.

SR: OK, thank you. Um, and so weve talked about depression in terms of in terms of your brains ability to change its neurones and neuroplasticity and stress and chemical hormones, imbalances and things like that. But I know that a lot of people who are suffering from from depression get talking therapies. So what can a talking therapy do to the physical structure and behaviour of your brain?

DB: Yeah, it just seems sort of like theyre an odd leap to make, that you can talk someone into having sort of a reenergised brain. Well, the best therapy seem to be a combination of antidepressants and talking therapies, because you could argue that antidepressants will boost your brain activity back up to normal levels, but talking therapies can then sort of channel that new activity into more helpful, beneficial routes. And because I think a lot of talking therapies essentially just to them is trying to coach people or train people to think in or instinctively think in ways which are more beneficial than the usual, negative routes. Someone with depression will have a very negative mindset. Like they reflexively think the worst is going to happen or the worst has happened, or they are unpleasant person unworthy of love and respect and concern and things like that. And if you can stop them doing that, that can sort of break the cycle because a lot of these mental health problems are kind of self-fulfilling. Then if youre anxious, you look for things to be worried about. And because of how full our brains are, youll find them. Exactly, I should worry about that. They should have been a big thing to worry about. I mean, I think its quite telling that for diagnosing depression, you have to have the symptoms for two weeks for diagnosis, according to both the ICD 10 and the the of the DSM. The the main text for mental health diagnosis, so for depression is like two weeks of sustained symptoms. But for anxiety, its in the region of six months, and which sort of shows like how much of our modern life anxiety is kind of a default. Yes. Are you worried about this? Yes. Its hard to think of that. I think if youre planning a wedding, thats a really big, big deal. Its a lot of work, a lot of pressure, a lot of effort. And its a massive life change, if its your wedding, of course. And that can take six months. So you can have six months of the symptoms of anxiety of just be constantly anxious and stressed for six months and have a perfectly valid reason for it, so its kind of hard to separate society from other things like that.

And talking therapies is sort of tend be all boil down to in terms of CBT, cognitive behavioural therapies at least, they try to coach people to think in ways which dont cause this sort of unhelpful outcome. So someone with depression, make them think in ways which dont result in them feeling so negative about themselves or the world or some of the anxiety talk about dont talk them into doing things or thinking in ways which do not trigger this nervous, anxious, fearful mindset. And its you can argue its kind of like reprogramming a computer, just thinking like this is a bad pathway. Do this one instead and do a workaround. And I guess the analogy I use in the book, which Im sort of happy with and people have approved of, is that if you think of like your functioning mental state as your home and you travel to and from it to do what youre doing. So one day theres a bridge that leaves your house. Thats how you normally achieve your good mental state, your regular mental state. Then one day it collapses. Could be because of trauma, because of general tear or just a flaw in the structure we didnt know about. So the bridge collapses while youre on the other side. So you need to get back to your home, your regular mental state, and you cant get there because the usual route is denied to you now. So the medical route, like using drugs, would be someone come along and build a new bridge, maybe not as good or maybe a pontoon or maybe its just the scaffolding or a big plank or something. But you can get you there. Its not perfect and its bit more treacherous. But that also involves you just there waiting for that to happen when youre outside cold and wet. Whereas talking therapy would be more like someone come along and say, OK, so you cant get back to your house. Ive got a spare pair of boots. I got a map and a compass. Lets find another way around. And so theyre going to go downstream, see if you can find another way across and they sort of help you to find another route to your destination, which is your healthy, functioning, functional mental state. Ideally, you use both of these. So this person fixing the bridge, while Im going to find out way around. Between us, we will get back eventually. And thats why combined therapies tend to be the most effective overall, because youre taking two bites of the cherry. Youve got double the chance. And the brains been helped in two different ways, at least two. And thats always going to be more helpful, I suppose.

SR: You touched on this a bit with your wedding metaphor, so something that I wonder about anxiety disorders is that therw are often things going on in the world which are a genuine cause of anxiety, the emotion. So, anxiousness. Like climate change, or I suppose right now the pandemic going on. So theres a lot of people who would reasonably be feeling anxious about that. And so I sort of think, I dont know if this is correct, but I sort of think of an anxiety disorder is when youre feeling a lot of anxiety for something thats sort of unwarranted, thats something that doesnt really require that level of anxiety. So wheres the line between feeling anxiety all the time over something thats real and out there? Is that like a disorder or does it have to be something thats not, you know, feeling anxiety, the things that are actually going to going to hurt you?

DB: Yeah, youve got it spot on there. Thats anxiety disorders are normally recognised by the anxious response being disproportionate to what the source is. If someones worried about climate change, and thats obviously something big and massively important that we should be worried about doing is an existential issue. To be worried about that is logical. So if you cant be anxious about climate change for five years, and I imagine Greta Thunberg has been, then yes. Shes not got a disorder. Shes just got a logical perspective on whats going on. But I guess its a case of if youre anxious about climate change, the point where youre in your room, sort of huddled in the pillow, just constantly in the foetal position, cringing, shivering about the possibility of climate change.

That would be a disproportionate response because, yes, its right to be anxious about it. But this is debilitatingly anxious about something thats very much a long term thing. Youre going to walk out your front door and be hit in the face by climate change because its not a thing that can do that. And I think thats where a lot of the distinction comes in. Yes, you should be anxious about this thing, but should you be this anxious about it? But thats also where like the Diagnosising these things is really tricky. Its not like its some one bullet point, you go, right, these three things, youre anxious now. Well done. Have a certificate or whatever. Its really quite marked in that its so nebulous. Like this person. You can just have an anxious personality, you can be someone who is constantly worried about stuff. And thats not a disorder, thats your default state of being. Whereas someone else who is far more upbeat and far more chilled, if they became like that person, then that would maybe suggest an anxiety disorder because its atypical for them. And theres been some interesting data which shows that during the pandemic and the lockdown, youd expect people with depression and anxiety to have worse problems because theres more to worry about, more to be depressed about.

But what data there is suggests that if anything, these sort of plateaued. Theres been no obvious increase in some people reported a lessening of their symptoms if they had pre-existing conditions. And it does sort of make sense in a way that say, if youre anxious about things which arent there, which havent happened, then a pandemic hits. Thats sort of justifies your anxiety. Like people were worried the worst was going to happen. And then it does happen, they think, oh I wasnt unwell. Im just rational. I was correct. And that can be oddly reassuring. It can be a de-stressor because I think when the worst has happened, theres nothing to worry about anymore, I guess.

You know, it does take Before my father passed away, I was like hyper stressed for weeks on end and afterwards I wasnt stressed, I was grieving. It was the impact. But it was not as fraught because, you know, the worst happened. And Im never going to say thats a good thing. But it was a very different way of, you know, it was very different emotional experience in that respect. And thats going to be something which obviously will manifest in a lot of different people. Its how proportionate it is. Anxiety disorders are so wide-ranging as well. PTSD is an anxiety disorder, but so is generalised anxiety disorder. Generalised anxiety disorder say it has no specific cause for the anxiety youre feeling. PTSD has a very obvious cause for the anxiety problems youre feeling, because this is the one major traumatic event which caused this to happen. But they both have anxiety disorders because symptomatically they have similar properties and seem to affect us in similar ways in the brain. But even like low level things like phobias, one of the more common anxiety disorders like arachnophobia is a very well known phobia. And a lot of people dont like spiders, but arachnophobia, if you are actually really terrified of them, I think the most perhaps frustrating part of it is for people with that, they know that its not logical. You can tell them all you want. Dont be afraid of that spider. Its like the size of a two pence coin on the other side of the room. Its not going to hurt you. On a logical level, people, arachnophobia will know that. But the fact is that they dont react like that because the more fundamental subconscious part of their brain which deals with that, theyre theyre in control. So they think spider, scream, jump, run. They fire up the fight or flight response, whether you like it or not. And you have this extreme panic reaction, which is illogical, but that doesnt stop it. And so what happens with anxiety disorders, its like the response is disproportionate or unwarranted to what the trigger is, if there is one. Sometimes they dont have a trigger. Like, panic disorder is a real thing like that in that theres no obvious cause for these panic attacks. And thats why theyre so debilitating and so problematic. You cant anticipate that, you cant do anything about them. And I address this in the book, too. Some evidence suggests that the panic attacks are normally caused by novel stimuli. So it literally has to be something unexpected which causes it, and therefore you cant do anything about it. And they become so problematic because theres no real workaround outside of therapy and things. So, yeah, so youre right in that its going to be something people anxiety all the time. But when its doing when the anxiety has no obvious cause or is way more than the cause warrants, thats when you think, OK, thats not meant to be happening.

SR: That was Dean Burnett, author of Psycho-logical. His book is out now. Thank you for listening to this episode of the Science Focus Podcast. The January issue of BBC Science Focus Magazine is out now. Also in this issue, we explore the greatest mysteries of the universe. Dr Michael Mosley says his top tips for keeping your blood pressure on track. And as always, our panel of experts answering your questions. Of course, theres much more inside and on sciencefocus.com.

Listen to more episodes of theScience Focus Podcast:

More:
Dean Burnett on the neuroscience of mental illness - BBC Focus Magazine

Activision Blizzard Media, Alter Agents and Immersion Explore Impact of Advertising on Esports Audiences Compared to Traditional Sports Audiences -…

LOS ANGELES, Feb. 16, 2021 /PRNewswire/ -- Activision Blizzard Media engaged market research firm Alter Agents and neuroscience experts at Immersion to complete a study on the emotional impact of advertising and sponsorships on esports versus traditional sports viewers. The multi-cell, trimodal research study found that during sponsorship ads, the immersion (measured as the attention and emotional response of the viewer) was more sustained for esports viewers.

"Savvy marketers are learning that esports is a substantial conduit to a young, affluent and valuable audience. To match this savvy, esports platforms need to recognize that the onus is on us to empirically demonstrate the power of this platform and these audiences," said Jonathan Stringfield, VP, Global Business Marketing, Measurement and Insights, Activision Blizzard Media. "The findings from our immersive biometric study with Alter Agents and Immersion show that ads during esports keep viewer attention, perform higher and boost positive brand perception."

The research, which was conducted in late 2020, consisted of a survey of esports and traditional sports viewers from 16-40 years old. A series of in-depth respondent interviews to provide context and color to the findings. Emotional response sessions were conducted using Immersion's distributed and real-time neuroscience platform to reveal advertising's emotional impact at a physiological level.

Specifically, the data indicated that:

Esports outperformed traditional sports on key immersion metrics, demonstrating its merit in delivering measurable impact for brands. The findings show that esports is a legitimate and effective advertising media channel, which can reach, engage and positively impact target audiences.

About Activision Blizzard Media

Activision Blizzard Media Ltd is the gateway for brands to the leading interactive entertainment company with hundreds of millions of monthly active users around the world. Our legendary portfolio includes iconic mobile game franchises such as Candy Crush, esports like the Call of Duty League, the Overwatch League and some of the top PC and console gaming franchises such as Call of Duty, World of Warcraft, and StarCraft. The idea is simple: great game experiences offer great marketing experiences. Learn more at http://www.activisionblizzardmedia.com

About Alter Agents

Alter Agents is a full-service market research consultancy reimagining research in the age of the constant change. With a long history of brand strategy and communications experience, the company focuses on collaborating with brands to reveal consumer needs, priorities, and context. Alter Agents specializes in reframing the context for consumer research to yield powerful insights for its clients, including brand giants such as SnapChat, YouTube, Activision, Viking Cruises, and many more. http://www.alteragents.com @Alter_Agents

About ImmersionImmersion is a distributed neuroscience SaaS, which provides a second-by-second measure of what people's brains value - anywhere & anytime - using the smartwatches they wear every day. Customers use our platform to predict buying, sharing, downloads, and information recall with over 80% accuracy. Immersion measures what the world loves, especially when the cost of being wrong is high. http://www.getimmersion.com

Media contact: Marie Melsheimer, 541-815-3951, [emailprotected]

SOURCE Alter Agents

Follow this link:
Activision Blizzard Media, Alter Agents and Immersion Explore Impact of Advertising on Esports Audiences Compared to Traditional Sports Audiences -...

Rochester brain and cognitive sciences researchers receive national recognition – University of Rochester

February 16, 2021

Martina Poletti. (University of Rochester photo / J. Adam Fenster)

Emanuel Gomez-Ramirez. (University of Rochester photo / J. Adam Fenster)

Two University of Rochester researchers in the Department of Brain and Cognitive Sciences are being honored with a celebrated award for their contributions to and leadership in the scientific community.

Martina Poletti and Manuel Gomez-Ramirez, both assistant professors of brain and cognitive sciences and of neuroscience, are among this years recipients of Sloan Research Fellowships. Awarded annually by the Alfred P. Sloan Foundation since 1955, the fellowships recognize young scientists for their independent research accomplishments, creativity, and potential to become leaders in the scientific community. Each fellowship carries a $75,000, two-year award. This year, 128 scientists across the US and Canada were awarded fellowships. Gomez-Ramirez and Poletti are the Universitys fourth and filth Sloan fellows in the last three years.

Poletti, together with Michele Rucci, professor of brain and cognitive sciences, runs the Active Perception Lab in the Department of Brain and Cognitive Sciences. Her research focuses on how humans perceive the world by taking in visual information through a combination of sensory processing, motor behavior, and attention. In particular, she studies the foveolaa small region of the retina that is essential for high-resolution visionand how the foveola works in tandem with microscopic eye movements and attention to enable vision.

Martina has made critical discoveries that have led to a complete change in how we think about fixational eye movements and the function of the fovea, says Duje Tadin, professor and chair of the Department of Brain and Cognitive Sciences. Her recent work has made major advances linking fixational eye movementsseemingly among the lowest levels of visual functionto higher aspects of visual functioning, including attention, visual exploration, and task-relevance.

Poletti joined the Rochester faculty in 2017, after serving as a research assistant professor at Boston University. She received her PhD in cognitive and neural systems from Boston University in 2010.

Gomez-Ramirez leads the Haptic Perception Lab in the Department of Brain and Cognitive Sciences. His research focuses on the mechanisms that enable our hands to perceive, grab, and manipulate objects. The research is important in optimizing brain-computer interfaces and developing neuroprosthetics that integrate brain signals with prosthetic devices in order to control the devices.

This is a challenging area to study as it often involves difficult experiments, but Manny recognizes its importance as a great model of how the brain combines information from multiple sourcesa fundamental question in neuroscience, Tadin says.

Gomez-Ramirez joined the Rochester faculty in 2019 after serving as a research associate at Brown University and a postdoctoral research associate at Johns Hopkins University. He received his PhD in psychology from the City University of New York in 2009.

Tags: Arts and Sciences, Department of Brain and Cognitive Sciences, Manuel Gomez-Ramirez, Martina Poletti, research funding, Sloan Research Fellowships

Category: Science & Technology

Visit link:
Rochester brain and cognitive sciences researchers receive national recognition - University of Rochester

Midwest Women in Agriculture Conference to take on food bullying – Purdue News Service

WEST LAFAYETTE, Ind. The 2021 Midwest Women in Agriculture Conference kicks off at 9:30 a.m. ET Feb. 25 for a full day of special guest speakers, breakout sessions and networking opportunities.

Michele Payn, founder of Cause Matters Corp., a company that connects farming and food, is the morning keynote speaker. Payn will illustrate how trends in neuroscience and psychology are changing common perceptions surrounding farming and agriculture. She will examine how trends have led to bullying within agriculture and how the agriculture industry can be more compassionate and share the complexities of the food system with consumers.

Breakout sessions throughout the day will cover the following topics: tractor and equipment maintenance, business management and leadership, building and strengthening relationships, and leading operations through volatility. In the afternoon session Monica McConkey, a rural mental health specialist in Minnesota, will share strategies to build self-confidence during challenging times.

Visit ag.purdue.edu/extension/WIA/Pages/default.aspx to register and view the conference agenda. Conference registration is $40. Attendees will receive a special swag bag after registration. For accommodation or more information, contact Kelly Heckaman at 574-372-2340 or kheckaman@purdue.edu.

Writer: Abby Leeds, 765-494-7817, mayer36@purdue.edu

Source: Kelly Heckaman, 574-372-2340, kheckaman@purdue.edu

Agricultural Communications:765-494-8415;

Maureen Manier, Department Head,mmanier@purdue.edu

Agriculture News Page

Excerpt from:
Midwest Women in Agriculture Conference to take on food bullying - Purdue News Service

Study explores the effects of alcohol and cannabis on aggression-linked brain circuitry in teens – News-Medical.Net

Alcohol and cannabis use during adolescence is a well-known risk factor for alcohol use disorder (AUD) and cannabis use disorder (CUD) during adulthood. Whether early drug use plays a causative role in predisposing teens to AUD and CUD is unknown, but researchers are investigating the possibility that it may have an impact on neural development. Evidence suggests that an increased propensity for aggression may underlie the risk.

Now, a study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier, shows that teens with more severe AUD or CUD displayed stronger retaliatory behaviors, but only those with AUD - and not CUD - had altered brain activity in aggression circuits.

One clue about substance use and risk for future AUD or CUD has emerged from the strong association between AUD and CUD and conduct disorder (CD), which includes increased aggressive behaviors. CD in young children can predict later substance use, suggesting that activity in neural networks involved in aggression may be a predisposing factor for substance use and abuse. In the current study, the authors hypothesized that, if heightened threat processing were a factor in AUD / CUD risk, then AUD / CUD severity would correlate with increased recruitment - or decreased regulation - of neural aggression circuitry.

R. James Blair, PhD, lead author of the study, and based at the Center for Neurobehavioral Research, Boys Town National Research Hospital, Boys Town, NE, USA said, "The findings indicated that, in adolescents, AUD severity in particular was associated with an exaggerated recruitment of regions implicated in retaliation, and that this relates to an increased risk for reactive aggression."

The study included 112 youths, aged 13 to 18 years of age, with substance use disorders or other mental health concerns. To assess neural processing associated with threat, the researchers used functional magnetic resonance imaging (fMRI) to evaluate brain activity in subjects during a retaliation task. For the task, participants were presented with a $20 USD pot to be split with a partner either "fairly," with each receiving $10, or "unfairly," in which the participant received $2, $4, or $6 while the partner received the larger balance.

As part of the game, participants could accept or reject the offer, and could spend "punishment dollars," each of which caused their partner to lose $7. Participants were then graded on their propensity to retaliate in the task.

The investigators compared participants' AUD or CUD severity with their likelihood to retaliate during the task. In general, the teens retaliated more strongly as the offers became less fair. But those with more severe CUD were more likely to retaliate at lower levels of unfairness.

Surprisingly, AUD severity was not associated with higher retaliation behavior. AUD severity, however, was associated with disordered neural activity in key brain areas linked to aggression and retaliation.

This work shows how noninvasive brain imaging can be used to provide new information about the differential effects ofalcohol and cannabis use on brain function in young people with conduct disorder."

Cameron Carter, MD, Editor, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

The study could not differentiate between the possibility that alcohol use affected the brain activity or whether the fMRI findings represented existing risk factors for AUD. In any case, the results suggest that alcohol and cannabis may affect brain circuitry differently and have different mechanisms for imparting future risk for abuse.

Source:

Journal reference:

Blair, R.J., et al. (2020) Alcohol Use Disorder and Cannabis Use Disorder symptomatology in adolescents and Aggression: Associations with recruitment of neural regions implicated in retaliation. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. doi.org/10.1016/j.bpsc.2020.11.016.

See the original post here:
Study explores the effects of alcohol and cannabis on aggression-linked brain circuitry in teens - News-Medical.Net

New study suggests genetic testing could be appropriate for all motor neuron disease (MND) patients whether or not they have a family history of the…

Research from the Sheffield Institute for Translational Neuroscience (SITraN) suggests that routine genetic testing may be appropriate for all MND patients and could impact disease subclassification and clinical care.

Research from the Sheffield Institute for Translational Neuroscience (SITraN) suggests that routine genetic testing may be appropriate for all MND patients and could impact disease subclassification and clinical care.

The new study, published today (15 February 2021) in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP), performed targeted genetic sequencing of MND-relevant genes on 100 patients.

Researchers found higher than expected genetic changes in the group of patients. The paper recommends that genetic testing could be appropriate for all MND patients whether or not they have a family history of the disease.

While the majority of MND cases are considered sporadic, five per cent to 10 per cent have been shown to be familial. Currently only patients with a family history of MND, dementia, or who experience disease onset at a young age are routinely offered genetic screenings in the UK. However, with the development of new therapies targeting specific genetic forms of the disease, researchers are recommending that all MND patients are offered a screening.

Prof Janine Kirby, Professor of Neurogenetics at the University of Sheffield, said Our study found that 42 per cent of patients involved in the screening showed variants in known MND-linked genes. This doesnt mean that 42 per cent of MND cases are familial - but shows that some familial and sporadic cases can share the same genetic cause of disease.

We found that 21 per cent of patients had a clinically reportable genetic alteration that has been proven to increase the likelihood of developing MND. Of these, 93 per cent had no family history of MND and 15 per cent met the inclusion criteria for a current MND gene therapy clinical trial.

As future studies expand the number of verified genetic causes of MND, we will continue to see if they are also found in cases without a family history.

Professor Dame Pamela Shaw, Director of SITraN and the NIHR Sheffield Biomedical Research Centre said Our study suggests that all patients with MND should, with careful counselling, be offered genetic testing.

We hope that by screening all MND patients for gene mutations that are a known factor in MND, we can further our knowledge on subclassification of the disease, but also ensure that patients have access to clinical trials that are relevant for them personally."

This is increasingly important in light of the new personalised medicine treatments in development for MND that target a specific gene mutation to ensure that patients have access to potential treatments that could be beneficial to them.

Dr Brian Dickie, Director of Research Development at the Motor Neurone Disease Association said MND is a complex disease involving a complex mix of genetic and environmental factors. This latest research sheds more light on the genetic component and will hopefully lead to greater availability of genetic testing to aid earlier diagnosis and more tailored treatments in the future.

This study was supported by funds raised through the Ice Bucket Challenge and will be widened to include analysis of additional samples from two other clinics collaborating on this MND Association funded project. This will provide an even clearer picture of the UK MND genetic landscape.

MND - also known as amyotrophic lateral sclerosis (ALS) - is an adult-onset neurodegenerative disease characterised by progressive injury and cell death of upper and lower motor neurons. This leads to progressive failure of the neuromuscular system with death, usually from respiratory failure, within 25 years of symptoms in most cases.

Currently, there is no cure for MND and no effective treatments to halt or reverse the progression of this devastating disease.

The National Institute for Health Research (NIHR) is the nations largest funder of health and care research. The NIHR:

The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR commissions applied health research to benefit the poorest people in low- and middle-income countries, using Official Development Assistance funding.

This work uses data provided by patients and collected by the NHS as part of their care and support and would not have been possible without access to this data. The NIHR recognises and values the role of patient data, securely accessed and stored, both in underpinning and leading to improvements in research and care. http://www.nihr.ac.uk/patientdata

View post:
New study suggests genetic testing could be appropriate for all motor neuron disease (MND) patients whether or not they have a family history of the...

Neuroscience Antibodies and Assays Market 2021| COVID-19 UPDATE Future Challenges and Industry Magnification Perspective 2027 Key Companies Rockland…

This report studies the Neuroscience Antibodies and Assays Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Neuroscience Antibodies and Assays Market analysis segmented by companies, region, type and applications in the report.

The report offers valuable insight into the Neuroscience Antibodies and Assays market progress and approaches related to the Neuroscience Antibodies and Assays market with an analysis of each region. The report goes on to talk about the dominant aspects of the market and examine each segment.

Key Players: Rockland Immunochemicals, Merck KGaA, Cell Signaling Technology, F. Hoffmann-La Roche, Tecan, Siemens, Bio-Rad, BioLegend, Santa Cruz Biotechnology, Abcam, Thermo Fisher Scientific, and GenScript

Our new sample is updated which correspond in new report showing Post impact of COVID-19 on Industry

Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-neuroscience-antibodies-and-assays-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?utm_source=neighborwebsj&utm_medium=36

The global Neuroscience Antibodies and Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroscience Antibodies and Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2020-2026.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Neuroscience Antibodies and Assays market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Neuroscience Antibodies and Assays market by identifying its various sub segments.

Focuses on the key global Neuroscience Antibodies and Assays players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Neuroscience Antibodies and Assays with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Neuroscience Antibodies and Assays submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

Table of Contents: Neuroscience Antibodies and Assays Market

Chapter 1: Overview of Neuroscience Antibodies and Assays Market

Chapter 2: Global Market Status and Forecast by Regions

Chapter 3: Global Market Status and Forecast by Types

Chapter 4: Global Market Status and Forecast by Downstream Industry

Chapter 5: Market Driving Factor Analysis

Chapter 6: Market Competition Status by Major Manufacturers

Chapter 7: Major Manufacturers Introduction and Market Data

Chapter 8: Upstream and Downstream Market Analysis

Chapter 9: Cost and Gross Margin Analysis

Chapter 10: Marketing Status Analysis

Chapter 11: Market Report Conclusion

Chapter 12: Research Methodology and Reference

Key questions answered in this report

What will the market size be in 2026 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Get complete Report @ https://www.reportsandmarkets.com/sample-request/global-neuroscience-antibodies-and-assays-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?utm_source=neighborwebsj&utm_medium=36

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

https://neighborwebsj.com/

See the article here:
Neuroscience Antibodies and Assays Market 2021| COVID-19 UPDATE Future Challenges and Industry Magnification Perspective 2027 Key Companies Rockland...

Know your body and your headache symptoms, and understand there are specialists who can help – Norton Healthcare

Understanding the types of headaches and which kind are affecting you can help you understand better whether your primary care provider or a headache specialist can help.

If youre uncomfortable or your life is being disrupted, please dont hesitate to seek help, said neurologistBrian M. Plato, D.O., headache and migraine specialist with Norton Neuroscience Institute.

There are two broad types of headaches: primary and secondary. Primary headaches are their own condition and are not caused by another condition. Examples are tension type headache and migraine. Secondary headaches can result from medication overuse, trauma to the head, infections or other causes.

The most common forms of daily headache are chronic tension-type headache and chronic migraine, both of which are primary disorders Dr. Plato said.

The areas leading providers of migraine and headache care are now available with Norton Telehealth and shorter wait times for appointments.

(502) 899-6782

A chronic tension-type headache occurs more than 15 days per month. Symptoms include aching head pain and contraction of muscles between the head and neck. Patients often describe the feeling as a tight band around their head, according to Dr. Plato.

When medical attention can help:

Migraines are typically more severe than tension-type headaches and can last anywhere from a couple of hours to a couple of days. Common symptoms are nausea, vomiting and heightened sensitivity to light and sound. Many patients also report a throbbing pain, generally on one side of the head.

When medical attention can help:

Seek urgent medical attention for a sudden thunderclap headache or neurological symptoms such as weakness, numbness or inability to speak.

The American Headache Societys SNOOP acronym helps to break down secondary headaches and evaluate how dangerous they may be.

We have specialists who have dedicated their careers to the study and treatment of headache disorders, but it starts with you. Know your body, know your symptoms, but most of all know that these are serious conditions that can be debilitating, Dr. Plato said.

Read the original here:
Know your body and your headache symptoms, and understand there are specialists who can help - Norton Healthcare